Search
Latest Posts
- Private equity acquires a taste for drug development
- Equities, bonds ETFs drew in near-record amounts of cash in 2022
- UK battery startup Britishvolt in talks to sell majority stake
- AstraZeneca boosts heart, kidney business with $1.8 bln CinCor deal
- Stocks extend solid start to year, oil prices rebound